ASA president discusses at home use of ketamine for depression in Wall Street Journal

In the article, Michael W. Champeau, M.D., FASA, expressed patient safety concerns on how startups are prescribing ketamine tablets or lozenges online to treat serious mental-health conditions at home without proper medical supervision. “Giving any drug like that has the potential to cause general anesthesia at home in a completely unmonitored environment,” he said.